14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Making fair comparisons in pregnancy medication safety studies: An overview of advanced methods for confounding control

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Understanding the safety of medication use during pregnancy relies on observational studies: However, confounding in observational studies poses a threat to the validity of estimates obtained from observational data. Newer methods, such as marginal structural models and propensity calibration, have emerged to deal with complex confounding problems, but these methods have seen limited uptake in the pregnancy medication literature. In this article, we provide an overview of newer advanced methods for confounding control and show how these methods are relevant for pregnancy medication safety studies.

          Related collections

          Most cited references36

          • Record: found
          • Abstract: found
          • Article: not found

          High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.

          Adjusting for large numbers of covariates ascertained from patients' health care claims data may improve control of confounding, as these variables may collectively be proxies for unobserved factors. Here, we develop and test an algorithm that empirically identifies candidate covariates, prioritizes covariates, and integrates them into a propensity-score-based confounder adjustment model. We developed a multistep algorithm to implement high-dimensional proxy adjustment in claims data. Steps include (1) identifying data dimensions, eg, diagnoses, procedures, and medications; (2) empirically identifying candidate covariates; (3) assessing recurrence of codes; (4) prioritizing covariates; (5) selecting covariates for adjustment; (6) estimating the exposure propensity score; and (7) estimating an outcome model. This algorithm was tested in Medicare claims data, including a study on the effect of Cox-2 inhibitors on reduced gastric toxicity compared with nonselective nonsteroidal anti-inflammatory drugs (NSAIDs). In a population of 49,653 new users of Cox-2 inhibitors or nonselective NSAIDs, a crude relative risk (RR) for upper GI toxicity (RR = 1.09 [95% confidence interval = 0.91-1.30]) was initially observed. Adjusting for 15 predefined covariates resulted in a possible gastroprotective effect (0.94 [0.78-1.12]). A gastroprotective effect became stronger when adjusting for an additional 500 algorithm-derived covariates (0.88 [0.73-1.06]). Results of a study on the effect of statin on reduced mortality were similar. Using the algorithm adjustment confirmed a null finding between influenza vaccination and hip fracture (1.02 [0.85-1.21]). In typical pharmacoepidemiologic studies, the proposed high-dimensional propensity score resulted in improved effect estimates compared with adjustment limited to predefined covariates, when benchmarked against results expected from randomized trials.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Identification of Causal Effects Using Instrumental Variables

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008.

              The objective of the study was to provide information on overall medication use throughout pregnancy, with particular focus on the first trimester and specific prescription medications. The study design included the Slone Epidemiology Center Birth Defects Study, 1976-2008, and the National Birth Defects Prevention Study, 1997-2003, which together interviewed more than 30,000 women about their antenatal medication use. Over the last 3 decades, first-trimester use of prescription medication increased by more than 60%, and the use of 4 or more medications more than tripled. By 2008, approximately 50% of women reported taking at least 1 medication. Use of some specific medications markedly decreased or increased. Prescription medication use increased with maternal age and education, was highest for non-Hispanic whites, and varied by state. These data reflect the widespread and growing use of medications by pregnant women and reinforce the need to study their respective fetal risks and safety. Copyright © 2011 Mosby, Inc. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                mollie.wood@gmail.com
                Journal
                Pharmacoepidemiol Drug Saf
                Pharmacoepidemiol Drug Saf
                10.1002/(ISSN)1099-1557
                PDS
                Pharmacoepidemiology and Drug Safety
                John Wiley and Sons Inc. (Hoboken )
                1053-8569
                1099-1557
                17 October 2017
                February 2018
                : 27
                : 2 ( doiID: 10.1002/pds.v27.2 )
                : 140-147
                Affiliations
                [ 1 ] PharmacoEpidemiology and Drug Safety Research Group, School of Pharmacy University of Oslo Norway
                [ 2 ] Department of Quantitative Health Sciences University of Massachusetts Medical School Worcester MA USA
                [ 3 ] Department for Health Evidence, Radboud Institute for Health Sciences Radboud University Medical Center Nijmegen The Netherlands
                [ 4 ] Radboud REshape Innovation Center Radboud University Medical Center Nijmegen The Netherlands
                [ 5 ] School of Social and Community Medicine University of Bristol UK
                [ 6 ] Department of Child Mental and Physical Health Norwegian Institute of Public Health Oslo Norway
                Author notes
                [*] [* ] Correspondence

                M. E. Wood, PharmacoEpidemiology and Drug Safety Research Group, School of Pharmacy, University of Oslo, Norway.

                Email: mollie.wood@ 123456gmail.com

                Author information
                http://orcid.org/0000-0002-9302-2641
                Article
                PDS4336 PDS-17-0079.R2
                10.1002/pds.4336
                6646901
                29044735
                ea8d844f-bcda-46f2-9e59-94670dc7e89e
                © 2017 The Authors. Pharmacoepidemiology & Drug Safety Published by John Wiley & Sons Ltd.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 24 February 2017
                : 29 August 2017
                : 18 September 2017
                Page count
                Figures: 2, Tables: 1, Pages: 8, Words: 3315
                Categories
                Review
                Reviews
                Custom metadata
                2.0
                pds4336
                February 2018
                Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.6.2 mode:remove_FC converted:23.07.2019

                Pharmacology & Pharmaceutical medicine
                Pharmacology & Pharmaceutical medicine

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content220

                Cited by16

                Most referenced authors524